Insulet PODD Enterprise value

Enterprise value at other companies

Eli LillyLLY

$1.12T+51.8%

Tandem Diabetes CareTNDM

$1.71B-1.1%

MedtronicMDT

$131.22B-3.2%

Beta BionicsBBNX

$660.48M+1.1%

Embecta Corp.EMBC

$1.7B-18.8%

Opko HealthOPK

$1.18B+9.8%

FAQ

What is Insulet's enterprise value?

Insulet (PODD) reported enterprise value of $10.99B in Q2 2026.

How has Insulet's enterprise value changed year-over-year?

Insulet's enterprise value decreased by 51.4% year-over-year, from $22.62B to $10.99B.

What is the long-term trend for Insulet's enterprise value?

Over 5 years (2020 to 2025), Insulet's enterprise value has grown at a 2.7% compound annual growth rate (CAGR), from $17.78B to $20.3B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.